SELECTIVE DYSREGULATION OF NITRIC-OXIDE SYNTHASE TYPE-3 IN CARDIAC MYOCYTES BUT NOT CORONARY MICROVASCULAR ENDOTHELIAL-CELLS OF SPONTANEOUSLY HYPERTENSIVE RAT
U. Bayraktutan et al., SELECTIVE DYSREGULATION OF NITRIC-OXIDE SYNTHASE TYPE-3 IN CARDIAC MYOCYTES BUT NOT CORONARY MICROVASCULAR ENDOTHELIAL-CELLS OF SPONTANEOUSLY HYPERTENSIVE RAT, Cardiovascular Research, 38(3), 1998, pp. 719-726
Objective: Recent studies indicate that endothelial type nitric oxide
synthase (NOS3) modulates cardiac systolic and diastolic function and
the inotropic responsiveness to beta-adrenergic agonists, and may affe
ct myocardial oxygen consumption. Although NOS3 is a constitutive prot
ein, its levels of expression can be modified by various physiological
and pathophysiological stimuli. We investigated whether the cell-spec
ific expression of NOS3 mRNA and protein are altered in cardiac hypert
rophy. Methods: Left ventricular cardiac myocytes and coronary microva
scular endothelial cells were freshly isolated from 12 week old male s
pontaneously hypertensive rat (SHR) and matched normotensive Wistar ra
t hearts. NOS3 protein levels were assessed by Western analysis, and m
RNA levels by RT-PCR and Southern blotting. Results: Left ventricular/
body weight ratios were significantly increased in SHR compared to Wis
tar controls, indicating significant hypertrophy. The levels of NOS3 p
rotein were markedly decreased in SHR compared to Wistar cardiac myocy
tes (by similar to 85%). By contrast, the expression of NOS3 mRNA norm
alized for GAPDH was increased similar to 3 fold in SHR cardiac myocyt
es relative to Wistar controls. Tn freshly isolated microvascular endo
thelial cells, however, levels of NOS3 protein and NOS3 mRNA were simi
lar between the two groups. Conclusions: The expression of NOS3 is sel
ectively altered in cardiac myocytes but not coronary microvascular en
dothelial cells of young SHR hearts, with a marked decrease in NOS3 pr
otein but an increase in NOS3 mRNA. This dysregulation of NOS3 could c
ontribute to contractile dysfunction in left ventricular hypertrophy.
(C) 1998 Elsevier Science B.V. All rights reserved.